| Name | tomelukast |
|---|---|
| Synonyms |
MFCD00211057
Ethanone, 1-[2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl]- Tomelukast 1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone 1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl}ethanone Tomelukastum |
| Description | Tomelukast (LY171883) is an orally active leukotriene D4 and E4 antagonist. Tomelukast can be used for the research of asthma[1]. |
|---|---|
| Related Catalog | |
| Target |
leukotriene D4, leukotriene E4[1] |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 553.0±60.0 °C at 760 mmHg |
| Melting Point | 117-119℃ |
| Molecular Formula | C16H22N4O3 |
| Molecular Weight | 318.37 |
| Flash Point | 288.3±32.9 °C |
| Exact Mass | 318.169189 |
| PSA | 100.99000 |
| LogP | 3.27 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.574 |
| Storage condition | Store at +4°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | KM5780800 |
|
~76%
88107-10-2 |
| Literature: Bernstein; Vacek Synthesis, 1987 , # 12 p. 1133 - 1134 |
|
~%
88107-10-2 |
| Literature: US4661505 A1, ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |